INS and metabolic syndrome: This acquired form typically manifests as fat atrophy at the insulin injection sites, often accompanied by local fat hypertrophy, insulin resistance, and metabolic disturbances such as hypertriglyceridemia and dyslipidemia, which complicate the management of diabetes [1].